Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Ameluz (aminolevulinic acid)
i
Other names:
BF-200 ALA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Biofrontera
Drug class:
Photosensitizer
Related drugs:
‹
verteporfin (10)
5-ALA with CV01 (0)
ALA sonodynamic therapy (0)
fimaporfin (0)
hexaminolevulinate (0)
temoporfin (0)
synthetic hypericin (0)
talaporfin (0)
methyl aminolevulinate hydrochloride 16.8% cream (0)
porfimer sodium (0)
REM-001 therapy (0)
padeliporfin (0)
DTBF (0)
X-PACT (0)
verteporfin (10)
5-ALA with CV01 (0)
ALA sonodynamic therapy (0)
fimaporfin (0)
hexaminolevulinate (0)
temoporfin (0)
synthetic hypericin (0)
talaporfin (0)
methyl aminolevulinate hydrochloride 16.8% cream (0)
porfimer sodium (0)
REM-001 therapy (0)
padeliporfin (0)
DTBF (0)
X-PACT (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream (NCT02685592)
Phase 4
Joint Authority for Päijät-Häme Social and Health Care
Joint Authority for Päijät-Häme Social ...
Completed
Phase 4
Joint Authority for Päijät-Häme Social and Heal...
Completed
Last update posted :
05/30/2018
Initiation :
02/01/2016
Primary completion :
03/01/2018
Completion :
03/01/2018
TERT • MITF
|
TERT mutation
|
Ameluz (aminolevulinic acid)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login